To examine prevalence and changes in symptoms of psychological distress over 1 year after initial cancer diagnosis in adolescent and young adult (AYA) patients with cancer. Sociodemographic and clinical predictors of changes in distress were examined.
INTRODUCTION
A diagnosis of cancer and its treatment promote a sense of vulnerability, sadness, and fear for patients, often resulting in psychological distress. 1 Studies report that 33% to 40% of patients with cancer indicate clinically significant levels of distress at diagnosis.
2, 3 High levels of distress negatively affect health-related quality of life, 4-6 satisfaction with care, 7, 8 and self-management after treatment.
9,10
Adolescents and young adults (AYAs) with cancer are particularly vulnerable to distress as a result of the intersection of disease and developmental stage. AYAs face unique challenges related to physical and cognitive development, identity, body image, autonomy, and employment.
11 Cancer challenges AYAs' abilities to deal with these developmental issues. 12 For instance, changes in physical appearance resulting from treatment (eg, losing hair) can negatively affect body image and interfere with identity development. 13, 14 When diagnosed with cancer, AYAs are often forced to become dependent on parents, spouses/partners, or family members while simultaneously discovering and experiencing newfound independence. 15 Cancer treatment and late effects also can interfere with education or employment plans. 15 These concerns may cause elevated levels of distress for AYAs with cancer. 13, 16 Research indicates that young adult patients with cancer (ie, Ͻ 45 years of age) report more negative psychosocial outcomes than do older patients. 17, 18 However, reports of the prevalence of clinically significant distress among AYAs is inconsistent, ranging from 6% to 41% depending on sample sizes, age range of samples, timing of data collection, and instrumentation. 2, 14, 19 Existing AYA literature suggests that greater distress is associated with being female, nonwhite, currently in treatment, and in higher levels of pain.
14, [20] [21] [22] However, most findings are limited to cross-sectional studies and do not monitor changes in distress levels throughout a continuum of care. Although one study of 65 AYA patients reported decreases in depression and anxiety at 1.5 years after diagnosis, 23 existing research indicates that some young adult survivors of cancer report clinically significant symptoms of depression and distress years after completion of therapy. 24, 25 Understanding changes in distress over the course of cancer treatment and the predictors of these changes is important in helping clinicians identify who is in need of psychosocial intervention and when to most effectively intervene. The present study adds to the current knowledge of AYAs with cancer by examining trajectories of distress during the year after initial diagnosis and the sociodemographic and clinical factors associated with these changes in distress over time.
PATIENTS AND METHODS
A longitudinal survey of AYA patients assessed psychological distress over 2 years after initial cancer diagnosis. The data were collected within the first 4 months of diagnosis and then again 6 and 12 months later. Participating institutions included three pediatric care institutions (Doernbecher Children's Hospital, Portland, OR; Christus Santa Rosa Children's Hospital, San Antonio, TX; and Children's Hospital, Los Angeles, CA) and two universityaffiliated adult care medical institutions (Oregon Health and Sciences University Hospital, Portland, OR; Cancer Therapy and Research Center, University of Texas, San Antonio, TX). Institutional review board approval was obtained from each participating site and coordinating center. Informed consent and/or assent were obtained from patients and parents. Physician approval was obtained before each patient was approached.
Patients
Research staff at each participating institution monitored clinic registration rosters and subsequently approached 286 eligible patients between March 2008 and April 2010. Fifty-eight patients did not participate, either because physicians denied access to patients who they believed were too sick to participate or patients refused to participate. Of 228 AYAs who consented to the study, 12 did not return a survey after providing consent, and one died. Thus, the overall participation rate was 75% (n ϭ 215). Eligibility criteria included age of 14 to 39 years, first diagnosis of any form of invasive cancer within the previous 4 months, and ability to read and understand English or Spanish. A 4-month eligibility window was determined based on referral patterns in which many AYA patients are first diagnosed in a communitybased setting and then transferred to tertiary care centers for further staging and treatment. The age range proposed for this study is the same as that in the National Cancer Institute's Progress Review Group on Adolescent and Young Adult Oncology.
26

Measures
The Brief Symptom Inventory-18 (BSI-18) contains 18 self-report items assessing psychological distress, 27 comprising a Global Symptom Index (GSI) and the following three subscales: depression (six items), somatization (six items), and anxiety (six items). A 5-point Likert scale (ranging from 0 [not at all] to 4 [extreme]) measures the extent to which a respondent has been bothered by a distress symptom over the past 7 days. Raw scores for the GSI and three subscales are converted to age-and sex-adjusted T scores for comparison to nonpatient community norms (mean, 50; standard deviation, 10). Higher scores indicate greater distress. An overall GSI score of Ն 63 or a score of Ն 63 on any two of the subscales suggests caseness for distress and need for further assessment by a mental health professional. The BSI-18 is a shortened version of the BSI (53 items), which has demonstrated reliability and validity in more than 400 research studies, including samples of healthy adolescents (age Ն 13 years). 28 Internal reliability of the BSI-18 in a large cohort of young adult survivors of childhood cancer ranged from 0.75 to 0.90. 29, 30 Sociodemographic information, including age, sex, race, employment/ school status, and relationship/marital status, was reported by patients. Age at diagnosis was categorized into three groupings (14 to 17, 18 to 25, and 26 to 39 years) to approximate developmental life stages.
11,31 Employment/school status and relationship status were assessed at each time point. Clinical data obtained from medical charts included type of cancer, types of treatment (chemotherapy, radiation, and surgery), and treatment status (on v off treatment). Surveillance, Epidemiology, and End Results codes were used to categorize cancer type into severity of disease. 32 The following three categories of severity of disease were generated: diseases with expected 5-year survival rates greater than 80%; diseases with expected 5-year survival rates between 50% and 80%; and all other invasive malignancies with expected 5-year survival rates less than 50%.
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Statistical Analysis
Descriptive statistics concerning demographic and clinical characteristics are presented. A linear mixed-effects model with random intercept and slope was used to analyze longitudinal changes in distress. Repeated measures of distress were considered as being nested within patients. The analysis of changes in distress included the following two levels: within-patient (level 1) and between-patient (level 2). At level 1, the outcome varies over time within individuals and is a function of individual-specific change parameters. At level 2, these individual-specific change parameters vary across patients and are modeled as a function of variables differing between individuals. 34 Variables having values that change over time within patients (time variant) are specified at level 1 34 and included time since baseline, treatment status, employment/ school status, and relationship/marital status. Between-patient variables (time invariant) included sex, race, age at diagnosis, and severity of disease.
We first analyzed temporal trajectories of the GSI and the three subscales (ie, depression, somatization, and anxiety) measured at the baseline, 6-month, and 12-month follow-ups. Bonferroni corrections were applied for multiple comparisons. For GSI, the level of statistical significance was set at P ϭ .017 to adjust for multiple comparisons across three time points; for the three subscales, statistical significance was set at P ϭ .008 to adjust for multiple comparisons across time points and dimensions of distress. Univariate and multivariate analyses examined associations of sociodemographic and clinical characteristics with changes in distress. In univariate analyses, we constructed models as a function of time since baseline, each predictor (at each measurement occasion if a predictor was time varying), and interaction between those two terms. We examined interactions to determine whether trajectories of distress over 1 year differed by subgroups and whether effects of time-varying predictors influenced changes in distress over time. A multivariate model was analyzed as a function of time, sociodemographic and clinical characteristics, and interactions between time and other covariates. We first analyzed a model including only time-invariant variables (ie, sex, race, age at diagnosis, and severity of disease) and then added time-variant variables (ie, employment/ school status, relationship/marital status, and treatment status) to evaluate whether time-specific conditions influenced a linear trend of distress over time. A backward selection method was used (P Ͻ .05) to identify a parsimonious model. Age at diagnosis, sex, relationship status, and severity of disease were excluded from the final model because those variables were insignificant for both intercept and slope estimates.
Attrition and missing data were minimal. One hundred eighty-nine (88%) of the total 215 patients answered either the 6-or 12-month follow-up survey or both. After excluding 14 deceased patients (7%), only 18 patients (8%) did not respond to any follow-up survey. No missing values were observed for sex, age at diagnosis, and severity of disease. Less than 2% of patients had missing data for relationship status or race, and 10% to 12% of observations had missing data for employment/school status, treatment status, and/or distress. We conducted multiple imputations. 35 We imputed missing values for live patients only, using the chained equations approach in regression models that included outcome variables as well as predictors in this study.
RESULTS
Two hundred fifteen patients completed the baseline survey, 179 patients completed the 6-month follow-up survey, and 165 patients completed the 12-month follow-up survey. Mortality accounted for 28% of total attrition at 12-month follow-up (n ϭ 14). There were no significant differences in demographic and clinical characteristics between the 50 patients lost to attrition and the 165 patients who responded at 12-month follow-up, except for age. Mean age of respondents (22.7 years) was significantly less than that of patients lost to attrition (26.9 years; t ϭ 2.97, P ϭ .003). Table 1 lists demographic and clinical characteristics at baseline.
Changes in Distress Over Time
At baseline, 60 respondents (28%) reported BSI-18 scores suggesting caseness for distress. Prevalence of clinically significant distress at the 6-month and 12-month follow-ups was 16% and 23%, respectively. Table 2 lists the observed means for distress scores at the three measurement points, adjusted (Bonferroni) significance levels for differences in means across time points, estimated levels of distress at baseline, and linear change rate of distress per 6 months. Internal reliability for the GSI and individual subscales ranged from 0.91 to 0.93 for the entire sample and from 0.83 to 0.92 for 86 respondents younger than 18 years of age. Figure 1 presents observed means (Table  2 ) and estimated linear changes of the GSI and subscales. In aggregate, participants reported significant decreases in the GSI and all three subscales from baseline to the 6-month follow-up. Increases in anxiety and GSI between the 6-and 12-month follow-ups were observed, but those increases were not statistically significant (Table 2) . Linear decline in GSI over 1 year (␤ ϭ Ϫ0.89, P Ͻ .05) was statistically significant. Decreases in depressive symptoms, somatization, and anxiety over 1 year were not significant (Table 2) .
Demographic and Clinical Predictors of Distress
Univariate analysis. Table 3 lists the results of univariate analyses. Being unmarried/unpartnered (␤ ϭ Ϫ1.38, P Ͻ .05) and nonwhite (␤ ϭ Ϫ1.19, P Ͻ .05) were associated with a significant linear decline in GSI over time. Although white patients reported significantly lower mean GSI scores at baseline than did nonwhite patients, their distress scores did not decrease significantly over time. Not being in school or not working was related to higher distress scores at each time point, and distress scores for those not in school or not working did not change significantly over time. Lastly, no significant differences in baseline distress and change in distress over time were observed as a function of age at diagnosis, sex, severity of disease, or treatment status.
Multivariate analysis. Table 4 lists results of the multivariate analysis. Model 1 included time-invariant variables, and model 2 built on both time-invariant and time-variant predictors. Although levels of distress significantly decreased over each 6 months in model 1, controlling for treatment status and employment/school status at each time point attenuated this linear decline in distress over time (model 2; ␤ ϭ Ϫ0.17, P ϭ .719). That is, distress seemed to be primarily a function of treatment status and employment/school status. After accounting for treatment status and employment/school status, the observed decrease in distress symptoms from baseline to the 12-month follow-up was neither statistically nor clinically significant.
Race seemed to be a significant predictor of distress at baseline in model 1. Individuals who identified themselves as Hispanic/Latino or other race categories showed greater distress at baseline than those identified as white (␤ ϭ 2.69, P Ͻ .05). Change rates in distress over Abbreviation: BMT, bone marrow transplantation.
‫ء‬
For some variables, the sum of numbers is not 215 because of missing data. †Question was worded as follows: "Are you currently married, living together as married, or in a significant committed relationship?" ‡Response categories included the following: on temporary medical leave/ disability; unemployed; and permanently unable to work. §Response categories included the following: employed full time; employed part time; full-time homemaker; and full-time student.
time did not significantly differ by race, so an interaction between race and time was not included in the model. However, after adding treatment status and employment/school status to the analytic model (model 2), race no longer significantly predicted distress at baseline (␤ ϭ 2.12, P ϭ .063). Treatment status and employment/school status were significantly predictive of distress at each time point. If individuals received any type of treatment at a given time point (ie, chemotherapy, radiation, and/or surgery), their distress was significantly higher than those who were not receiving treatment (␤ ϭ 2.00, P Ͻ .05). Being in school or employed at a given time was associated with lower distress (␤ ϭ Ϫ2.59, P Ͻ .01). The effects of treatment status or employment/school status on distress did not vary by time, so interactions between change rates and these variables were not included in the final model.
DISCUSSION
Psychological distress in recently diagnosed AYA patients with cancer exceeded population norms at the time of diagnosis, dipped at the 6-month follow-up, but returned to a level at the 12-month follow-up that exceeds population norms at a clinically meaningful level (Ͼ 0.5 standard deviations above the population mean).
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Data suggest that, on average, AYA patients with cancer experience high levels of distress at the time of diagnosis and at the time of their transition to survivorship.
Although we observed a statistically significant decline in distress over 1 year, that decline was attenuated by the increase in distress from 6 to 12 months after diagnosis. Furthermore, the increase in distress 
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www.jco.org from 6 to 12 months seems to be a partial function of a marginally significant increase in anxiety during this time period and may reflect AYA patients' survivorship concerns about the negative impacts of cancer on their future lives, including uncertainties about future health. The longitudinal decline in distress also seems to be a partial function of the reduction in somatic distress from baseline to the 12-month follow-up. The reduction in somatization may reflect a decrease in treatment-related symptoms over the first year of treatment and thus emphasizes the importance of symptom management to prevent distress in AYA patients.
The statistically significant yet relatively small linear reduction in distress over 1 year was attenuated when time-specific conditions related to treatment status and employment/school status were considered. This finding suggests two distinct peaks of distress corresponding to diagnosis and transition to off-treatment survivorship and also suggests that being uninvolved in school or work contributes to distress, which is consistent with previous studies of AYA survivors. 38 Interference with school/work may cause isolation or concerns about future employment opportunities or financial difficulties, all of which manifest distress. In contrast, remaining employed or in school during treatment helps AYAs maintain normalcy and social reintegration with friends, peers, and other, thus minimizing life disruption. Supportive counseling, vocational counseling, and school interventions that keep AYAs involved with coursework can mitigate the social, vocational, and academic life disruptions caused by cancer and its treatment into the survivorship phase of the cancer experience. Intercept score represents distress at baseline. †The slope represents the change in distress per 6 months. ‡P value represents whether the difference between subgroup means at baseline is statistically significant. For age at diagnosis and severity of cancer, ␣ levels were set at .025 after adjustment. For sex, relationship status, race, employment/school status, and treatment status, ␣ levels were set at .05.
§P value indicates whether there is a significant change in the subgroup mean distress over time. For age at diagnosis and severity of cancer, ␣ levels were set at .017 after adjustment. For sex, relationship status, race, employment/school status, and treatment status, ␣ levels were set at .025 after adjustment. P value represents whether there is a significant difference in the rate of change between the subgroups over time. For age at diagnosis and severity of cancer, ␣ levels were set at .025 after adjustment. For sex, relationship status, race, employment/school status, and treatment status, ␣ levels were set at .05. ¶Question worded as follows: "Are you currently married, living together as married, or in a significant committed relationship?" #Response categories for not occupied included the following: on temporary medical leave/disability; unemployed; and permanently unable to work. Response categories for occupied included the following: employed full time; employed part time; full-time homemaker; and full-time student. 
‫ء‬
Intercept score represent distress at baseline for the reference group (ie, patients who are white, off treatment, and not employed/in school).
†The slope represents the change in distress per 6 months for the reference group (ie, patients who are white, off treatment, and not employed/in school).
Meanwhile, being in active treatment also seems to be a primary driver of distress for AYAs in the first year after cancer diagnosis, thus supporting prior research identifying treatment elements (eg, chemotherapy exposure) as a significant predictor of distress. 38 While receiving treatment, AYA patients continue to experience treatmentrelated adverse effects and concerns about impending procedures or treatments, pain, and changed physical appearance.
14 These findings emphasize the need to reinforce AYA patients' abilities to manage the physical and psychological effects of cancer treatment and all it entails.
Finally, contrary to studies of distress in adult patients with cancer in which levels varied across cancer type, 2 the likelihood of reporting distress was equally distributed among AYAs regardless of whether they had a cancer with a high, medium, or low survival rate. A growing body of evidence suggests that the psychologically distressing problems resulting from cancer can be effectively addressed by psychosocial and peer support interventions. [39] [40] [41] [42] [43] [44] Distressed AYAs may benefit from mental health professionals and patient support organizations offering psychosocial and peer support services, regardless of the severity of their cancer. This study's strengths include an ethnically diverse sample derived from multiple tertiary care institutions. Although involving a broad age range of patients, age did not seem to be a significant correlate for any of the variables of interest. The findings are somewhat limited in that 25% of the eligible sample pool was inaccessible, presumably because these patients were too ill to participate. Their absence from the study may explain the lower prevalence of distress in this sample when compared with other studies of distress in patients with cancer, including newly diagnosed AYAs.
19 Also, lacking objective information about patients' health status, stage of disease, and treatment specifics (eg, chemotherapy agents, treatment toxicities), this study is limited in advancing our understanding of the extent to which symptoms or toxicity exposures contribute to distress either directly or indirectly through an increased likelihood of missing time at school or work. Future research should examine the relative and independent effects of school or work involvement and cancer context (eg, treatment or symptom burden) on distress. Lastly, the overrepresentation of patients with cancers with relatively low survival rates limits generalizability but may reflect normative referral patterns across the United States, where persons with more severe or lifethreatening cancer types are referred to tertiary treatment centers, whereas AYA patients with relatively higher survival rates more typically remain in community-based settings for care.
This study provides evidence of changes in psychological outcomes of AYA patients with cancer over the first year after diagnosis. Findings suggest that interventions to help manage cancer-and treatment-related symptoms and facilitate involvement in work or school may have the greatest effect in terms of reducing distress among AYAs. Also, the observed increase in distress from 6 to 12 months, when many AYAs are nearing completion of therapy, suggests importance of attending to the psychosocial and emotional support needs of AYAs as they transition into an off-treatment survivorship phase. Indeed, studies indicate that psychosocial and quality-of-life outcomes are worse for patients 1 year after initial diagnosis [45] [46] [47] and that the end of treatment and transition to off-treatment survival are often fraught with distress. 48, 49 Continued research is needed to understand how distress is related to quality of life, functional outcomes, treatment, and symptom burden at key time points throughout the continuum of care.
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